Can-Fite BioPharma Ltd.
NYSE · CIK 0001536196 · Fiscal year end 1231
Latest reported period: Latest published period
Revenue
$405,000
Operating Income
$-9.9M
Net Income
$-9.8M
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $405,000 | - | - |
| Operating Income | $-9.9M | - | - |
| Net Income | $-9.8M | - | - |
| Eps Basic | -5.97 | - | - |
| Eps Diluted | -5.97 | - | - |
| Cash And Equivalents | $5.5M | - | - |
| Total Assets | $9.5M | - | - |
| Shareholders Equity | $5.6M | - | - |
| Operating Cash Flow | $-8.9M | - | - |
| Capital Expenditures | $2,000 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 20-F | Can-Fite BioPharma Ltd. | 2026-03-26 | 0001213900-26-034447 |
| 6-K | Can-Fite BioPharma Ltd. | 2025-08-28 | 0001213900-25-081407 |